PIG-O inhibitors constitute a class of chemical compounds that specifically target Phosphatidylinositol Glycan class O (PIG-O), an enzyme that plays a crucial role in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. GPI anchors are vital glycolipids that tether proteins to the cell membrane, facilitating various essential cellular processes, including cell signaling, adhesion, and protein localization. PIG-O is primarily responsible for the transfer of mannose residues during the assembly of GPI anchors, making it a pivotal player in the GPI biosynthetic pathway. By functioning in this capacity, PIG-O contributes significantly to the proper formation of GPI-anchored proteins, which are integral for maintaining cellular structure and function.
Research into PIG-O inhibitors has provided insights into the biochemical pathways underlying GPI anchor synthesis. By inhibiting PIG-O, scientists can effectively dissect the roles of GPI-anchored proteins in different cellular contexts, exploring how these proteins contribute to processes such as immune response, cell differentiation, and membrane dynamics. The study of PIG-O inhibition enhances our understanding of the consequences of disrupted GPI synthesis on cellular behavior, signaling pathways, and overall cell physiology. Furthermore, investigations into these inhibitors reveal important interactions within the GPI biosynthetic machinery, helping to elucidate how cells regulate protein anchoring and membrane integrity. Overall, PIG-O inhibitors serve as valuable tools in biochemical research, facilitating a deeper comprehension of GPI metabolism and its multifaceted impact on cellular function and organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
A sodium ionophore that disrupts Golgi apparatus function, potentially inhibiting GPI anchor synthesis where PIG-O operates. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi apparatus structure and function, likely affecting the localization and activity of PIG-O. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting glycoproteins and indirectly impacting GPI anchor synthesis involving PIG-O. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Inhibits glycoprotein processing in the Golgi apparatus, potentially altering GPI anchor biosynthesis where PIG-O is involved. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Inhibits farnesyltransferase, potentially affecting the prenylation of proteins and indirectly influencing PIG-O function. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
An inhibitor of glucosidase I, potentially impacting glycoprotein processing and GPI anchor synthesis involving PIG-O. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
A glucosidase inhibitor that may impact the glycosylation process in the ER, indirectly affecting GPI anchor biosynthesis and PIG-O. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
An antifungal that disrupts ergosterol synthesis, potentially affecting membrane integrity and functions related to PIG-O. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
A polyene that binds to sterols, possibly disrupting cell membranes and affecting PIG-O's function in GPI anchor biosynthesis. | ||||||